Dementia affects millions worldwide; according to the World Health Organization, about 57 million people were living with dementia in 2021. Early manifestations can include mild cognitive impairment (MCI) and sleep disturbances, conditions that often co-occur and may influence progression to dementia. Prior research has identified several nutrients — including vitamin D — as potential contributors to cognitive health, prompting investigators to examine whether higher vitamin D intake is associated with better cognition in older adults who have both MCI and sleep problems.
The study reported in Sleep Medicine recruited 54 adults with either diagnosed or suspected MCI and complaints of poor sleep. The mean age of participants was approximately 67 years. The source describes the study as observational; no trial randomization or intervention protocol is reported in the article.
Investigators assessed cognition using the Montreal Cognitive Assessment (MoCA), a screening tool commonly used to evaluate global cognitive function in people with suspected MCI. Sleep quality and daytime sleepiness were measured with established self-report instruments: the Pittsburgh Sleep Quality Index (PSQI) and the Epworth Sleepiness Scale (ESS).
Participants reported their daily vitamin D supplement use and dose. The source specifies that intake was self-reported; no details in the article indicate that researchers measured serum 25-hydroxyvitamin D [25(OH)D] concentrations or confirmed adherence objectively.
At study conclusion, participants who reported taking 5,000 international units (IU) or more of vitamin D daily scored over 13% higher on the MoCA compared with those who did not take a vitamin D supplement. The article notes this corresponded to an approximate difference of four points on the MoCA.
Investigators framed the results cautiously. The senior author highlighted that vitamin D is a ubiquitous part of daily life but that its role in cognitive health remains under investigation. Because the study was observational, authors emphasized caution in interpreting the association and did not claim a causal effect. The source quotes the senior author noting the need for careful interpretation but does not include complete text of her remarks.
The source article reports several key facts but does not provide full methodological detail. Items not reported in the article include, where applicable:
Because the study sample was relatively small (n=54) and vitamin D intake was self-reported, these design features limit the ability to draw firm conclusions about causality or the generalizability of the findings.
This observational finding — that reported daily doses of 5,000 IU or more were associated with a roughly four-point (≈13%) higher MoCA score in older adults with MCI and sleep disturbances — is hypothesis-generating. It aligns with prior literature that implicates nutrition, including vitamin D, in cognitive aging, but it does not establish benefit or an evidence-based dosing recommendation.
Clinicians and researchers should interpret the result in light of the study’s observational design, small sample size, and the methodological gaps noted above. Randomized controlled trials that measure baseline and follow-up serum 25(OH)D, use standardized supplementation protocols, and control for confounding factors are necessary to determine whether higher-dose vitamin D supplementation can causally improve cognition in people with MCI and sleep disturbances.
Details in this rewrite are drawn from the Medical News Today summary of the Sleep Medicine study. The original article summarized main outcomes and study measures but did not report full methodological or statistical detail; where those specifics are absent from the source, they are noted here as not reported.